JAMA Dermatology

Papers
(The H4-Index of JAMA Dermatology is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Error in Author Name1158
Error in Author Surname in Byline192
Melanoma Screening151
Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?135
Group Omitted From Article Byline129
Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity128
Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination103
Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa98
Clinical and Pathological Spectrum of Prurigo Pigmentosa in Central European Individuals85
Assessment of Cutaneous Vasculitis and Quality of Life80
Recurrence Rate of Melanoma In Situ Excised With a 5-mm Excisional Margin79
Disordered Eating in Hidradenitis Suppurativa76
Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers74
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice69
Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia67
Tofacitinib for Treatment of Acquired Reactive Perforating Collagenosis67
Nicotinamide for Skin Cancer Chemoprevention64
Human Papillomavirus Diversity in Asian Individuals With Cutaneous Squamous Cell Carcinoma63
Smoking Cessation and Risk of Hidradenitis Suppurativa Development62
Asymptomatic Irregular Pigmented Lesions of the Vulva60
Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa59
Alopecia Areata59
Ultraprocessed Food Intake and Psoriasis59
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records58
Safety and Efficacy of ICP-332 for Moderate to Severe Atopic Dermatitis58
Parental E-Cigarette Use and Pediatric Atopic Dermatitis57
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis57
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database56
Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus55
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage55
Cutaneous Angiosarcoma54
JAMA Dermatology53
Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark53
Perceptions of US-Based Muslim Patients of Their Dermatology Care53
SIGLEC-1 Expression in a Cohort of Patients With Lupus Erythematosus Treated With Anifrolumab52
Treatment of Verruca Plana With Topical Combination of Calcipotriol and Fluorouracil52
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab51
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention50
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults50
Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement50
Preventing Hand-Foot Syndrome in Patients With Cancer49
Outcomes Associated With Combination Shaving and Cryosurgery Treatment in Patients With Keloid Scars48
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults48
Skin Cancer Care in US Veterans—Serving Those Who Served47
Current State of Dermatology Mobile Applications With Artificial Intelligence Features47
1.0815460681915